Research & Development: Page
-
PharmaVoice Team/PharmaVoice
Letter from the Editor
The pharmaceutical industry can no longer afford to be off-message — not even just once — in an exceedingly competitive marketplace. Silo busting continues to be a resounding theme in all areas of the industry, it’s a way to improve business processes, increase efficiencies, and stay on message. ...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Last Word
Throughout his career, Joseph Bolen, Ph.D., has been involved in unraveling the mysteries of drug discovery. Now in his positions as Senior VP of Research and Drug Discovery, a role in which he heads all biological research and related functions as well as all drug-discovery functions, and as Chi...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Strengthening the Value of Live CME: Cutting-Edge Strategies to Engage Learners and Extend Reach
VIEW on Medical Education August 2007 Strengthening the Value of Live CME: Cutting-Edge Strategies to Engage Learners and Extend Reach Sarah Mooney, Director, Strategic Planning & Development Innovia Education Institute LLC In 2006, more than 2 million physicians and healthcare pr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Transforming U.S. Healthcare Quality Using CME
Transforming U.S. Healthcare Quality Using CME VIEW on Medical Education August 2007 cme2 Cathy Pagano, Executive Director John Marlow, Chief Medical Officer We believe the mission of all CME needs to be elevated to a whole new level to be clinically meaningful. Looking ahead, a new model...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The True Value of Educational Outcomes Measurement
VIEW on Medical Education August 2007 The True Value of Educational Outcomes Measurement Sherri Foster, Senior VP and General Manager Outcomes measurement has become the buzzword in continuing medical education (CME) over the past few years. It comes amid growing recognition among stak...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A Process Map for Maximizing the Impact of Promotional Medical Education
A Process Map for Maximizing the Impact of Promotional Medical Education Neil Matheson CEO Axis Healthcare Communications LLC CME Planning The goal of all medical education programs is to improve patient care. This goal can be achieved if the participants in the program recognize and...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Emerging Psychographic Segmentation Strategies for Developing Customized Professional Education
Emerging Psychographic Segmentation Strategies for Developing Customized Professional Education David St. Peter, M.D. President VIEW on Medical Education August 2007 Why Customization Is Important Physicians are people too, and just like everyone else, they have innate differences th...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Letter from the Editor The Forum Medical Education: The State of CME — Continuing medical education could be argued to be one of the most ever-changing fundamentals in the healthcare industry today. Ensuring that CME remains in compliance with the latest guidelines and technologies is an ongoing ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Old School, New School Taren Grom We look forward to discussing the latest industry trends at the Annual Conference on CME Provider/Industry Collaboration, Oct. 17-19. Please stop by to say hello. Letter from the Editor VIEW on Medical Education August 2007 In September 2006, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Making Partnerships Work for Your Educational Programs
Making Partnerships Work for Your Educational Programs VIEW on Medical Education August 2007 Susan Grady, Chief Medical Director Haleh Kadkhoda, VP of Educational Programs Making the decision to collaborate on an educational initiative is not an easy one. Broach the subject with your team...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
No Crystal Ball Required: The Future of CME Is Already Here
No Crystal Ball Required: The Future of CME Is Already Here August 2007 VIEW on Medical Education E-CME Niki Oquist, M.D., FAAP, Senior VP, Medical Affairs Advances in technology are changing the way groups and individuals communicate with and amongst one another, and CME providers must embr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
PharmaVOICE 100 of the Most Inspiring People July/August 2007 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Strategic Patient Adherence Awards
The SPA Awards cosponsored by CBI and PharmaVOICE were presented at the 6th Annual Forum on Patient Compliance, Adherence and Persistency. 6th annual Forum on patient compliance, adherence and persistency Informative presentations, executive thought leadership, and a prestigious awards ceremony p...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies TGaS Advisors Offers Collaborative Benchmarking Services for Pharmaceutical Companies Pharmastance operational resource lets companies learn where they stand. TGaS Advisors has launched the Pharmastance family of benchmarks. These collabora...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Patient Advocates
With an unwavering commitment to patients and protecting their rights, these forward-thinking individuals are advocating best practices for clinical-trial recruitment and education. Zane Wilson Speaking up for Those in Need Despite an often uphill battle to provide better facilities for patients ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Researchers & Scientists
Matthew Coffey, Ph.D. Barry Eisenstein, M.D. Robert Lanza, M.D. Christine Smith Ana Szarfman, M.D., Ph.D. From discovery through clinical development, the researchers and scientists behind the medicines are making a significant impact on the pipelines of today and of the future. Current positions...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Technologists
These innovators of technology-based solutions are improving connections across silos to facilitate the drug-development process and customer interactions. PharmaVOICE 100 July/August 2007 Vikas Vats The Sky’s the limit for innovation Current position VP, marketRx Place and date of Birth New Delh...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Inverting the Enrollment Trend of Clinical Trials
Inverting the Enrollment Trend of Clinical Trials One of the largest challenges facing the industry today is inverting the trend of clinical trials failing to complete enrollment on time. Raising awareness of a particular clinical trial with call-to-action advertising, such as broadcast televi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Guidance and Technology: A Single-Source Solution
Guidance and Technology: A Single-Source Solution Rick Piazza, VP, Product Strategy In today’s technology-reliant clinical-trial studies, it is crucial that software providers maintain a staff of in-house experts to offer counsel and guidance to sponsors. These experts act as process partne...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
New Techniques Drive Patient Enrollment for Trials
New Techniques Drive Patient Enrollment for Trials The number of clinical trials for new drugs continues to grow, increasing the competition for patients. IMS data show that new drug-discovery technologies are fueling record worldwide growth. There are more than 13,000 studies projected for 20...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Clinical Services: Managing the Moving Parts
Clinical Services: Managing the Moving Parts By Taren Grom, Editor The Cost of Doing Business The cost of drug development remains on the rise, with most estimates showing that the clinical-trials stage alone accounts for 40% of all costs related to R&D. Our Forum experts discuss...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Letter from the Editor The Forum Clinical Services: Managing the Moving Parts — The clinical-research process is complex and requires integrated, sophisticated processes, technologies, and management to reduce costs, improve timelines, and produce safe therapeutics. Company Listing by Topic of In...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Integration and Workflow Issues for Clinical-Services Providers to Ensure Smooth Trials
Integration and Workflow Issues for Clinical-Services Providers to Ensure Smooth Trials Mary T. Stefanzick, Associate Director of Operations An ongoing imperative in clinical research for pharma and biotech companies is to accelerate processes and timelines to get new products to market ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Overcoming Poor Quality Data for ECG Collection
Overcoming Poor Quality Data for ECG Collection Timothy Callahan, Ph.D., Chief Scientific Officer The ICH E14 has become the touchstone guideline when designing and implementing Thorough QT (TQT) trials. Even protocols that are not designed primarily as a QT trial often use recommendations fr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Using Advanced Simulation in Clinical Operations
Using Advanced Simulation in Clinical Operations Jack Porter, President and CEO, ePharmamindshare The introduction of supercomputers and sophisticated simulation software for planning and optimizing clinical trials is rapidly becoming established in the pharmaceutical industry. These simulati...
By PharmaVoice Team • Jan. 2, 2008
Previous
